Loading data for CLDX — first visit, this takes a few seconds.
Celldex Therapeutics, Inc. (CLDX)
NasdaqCM: CLDX
· 实时价格 · USD
38.78
-0.34 (-0.87%)
收盘价： Sep 10, 2026, 12:12 PM
股价、关键数字和最新消息，都在这一页。
Celldex Therapeutics, Inc.（CLDX）股价、分析与数据
-0.87% (1D)
| 买价 | 33.48 |
| 市值 | 3.03B |
| 营收（TTM） | 158K |
| 净利润（TTM） | -301M |
| 0.84 | |
| -4.35 | |
| n/a | |
| -9.17 | |
| 市净率（TTM） | 4.24 |
| 市销率（TTM） | 19165.18 |
| 财报日期 | Nov 9, 2026 |
| 卖价 | 44.8 |
| 成交量 | 588,406 |
| 20日均量 | 1,014,557 |
| 开盘价 | 38.95 |
| 前收盘价 | 39.12 |
| 日内区间 | 38.67 - 40.03 |
| 52周区间 | 22.10 - 45.14 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 CLDX
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that spe...
公司完整简介财报意外
Celldex Therapeutics 已于 Aug 6, 2026 发布季度财报：
- 营收为 $22K 低于预期 $0, ， -96.99% 同比下滑.
- 每股收益为 -0.94 超出预期 0.12, ， -10.59% 同比下滑.
第 1 页，共 2 页